Monitoring of Liver Transplant Recipients

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Recruiting Observational Study
Liver Transplant Hepatitis C Chronic Kidney Disease Acute Rejection
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Northwestern University · Other
Who this trial is looking for

This trial is looking for adults who have received a liver transplant. Participants will provide blood, urine, and tissue samples to help detect early conditions that can affect kidney function and liver health.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old.
  • I have received a liver transplant.
  • I can provide informed consent or have a guardian who can.
  • I can follow the study instructions.

You may not be able to join if

  • I am unable or unwilling to provide informed consent.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Male and female recipients of all races, ≥18 years of age. 2. Patients undergoing primary or subsequent living or deceased donor liver transplantation. 3. Subject and/or guardian must be able to provide informed consent. 4. Subject and/or guardian must be able to comply with …
Contacts

Misael Villegas, BA

misael.villegas@northwestern.edu

CONTACT